Fulcrum Therapeutics, Inc. - 8-K Filing
Fulcrum Therapeutics enters asset purchase agreement to sell early-stage HbF assets for $7.0 million in cash. (Items: 8.01 Other Events)
Tickers: $FULC
Fulcrum Therapeutics enters asset purchase agreement to sell early-stage HbF assets for $7.0 million in cash. (Items: 8.01 Other Events)
Tickers: $FULC